Related Experiment Videos
Heterochromatic segment length of Y chromosome in 55 boys with malignant diseases
Cancer Genetics and Cytogenetics
|April 1, 1987
Abstract:
By investigating heterochromatic segment variability in a group of boys with malignant disease a significantly greater value of the Yc:F index in relation to the control subjects was established.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Signature of anyonic statistics in the integer quantum Hall regime.
Nature communications·2024
The role of tapentadol in cancer pain pharmacotherapy in patients with metastatic malignant disease.
European review for medical and pharmacological sciences·2024
Phase-Slip Statistics of a Single Isolated Flux-Biased Superconducting Ring.
Physical review letters·2020
Controlled dc Monitoring of a Superconducting Qubit.
Physical review letters·2020
A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
Cancer genetics and cytogenetics·2010
Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.
Cancer genetics and cytogenetics·2010
Screening for DNA copy number aberrations in mucinous adenocarcinoma arising from the minor salivary gland: two case reports.
Cancer genetics and cytogenetics·2010
Screening for common copy-number variants in cancer genes.
Cancer genetics and cytogenetics·2010
Trisomy 17 in congenital plexiform (multinodular) cellular schwannoma.
Cancer genetics and cytogenetics·2010
Chromosomal alterations in Malaysian patients with nasopharyngeal carcinoma analyzed by comparative genomic hybridization.
Cancer genetics and cytogenetics·2010
Natural Products as Anti-Angiogenic Agents: Molecular Targets, Signaling Pathways, and Mechanistic Insights.
Current pharmaceutical design·2026
Outcomes of Percutaneous Transhepatic Biliary Drainage in Patients With Malignant Biliary Obstruction Receiving Palliative Care.
The American journal of hospice & palliative care·2026
Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review).
International journal of oncology·2026